Literature DB >> 22882325

Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.

Farah Idali1, Said Zareii, Afsane Mohammad-Zadeh, Fakhreddin Reihany-Sabet, Zoreh Akbarzadeh-Pasha, Hamid-Reza Khorram-Khorshid, Amir-Hassan Zarnani, Mahmood Jeddi-Tehrani.   

Abstract

PROBLEM: Mutations in genes related to thrombophilia and hypofibrinolysis have been associated with recurrent pregnancy loss (RPL) and polycystic ovary syndrome (PCOS).
METHODS: Using PCR-RFLP, we investigated the frequencies of MTHFR (A1298C and C677T) as well as PAI-1 (-675 4G/5G) gene polymorphisms in 177 RPL and 100 control women. RPL women were stratified into 38 women with PCOS (RPL-PCOS), 33 with ovarian PCO (RPL-ovarian PCO), and 106 without PCOS (RPL).
RESULTS: RPL, RPL-PCOS, and RPL-ovarian PCO groups showed significantly higher frequencies of MTHFR A1298C (P < 0.001) and PAI-1 4G/5G (P < 0.001) mutations than the controls. No significant differences were found between the RPL groups. The respective odds ratios (OR) for bearing MTHFR (A1298C, C677T) and PAI-1 (4G/5G) gene mutations were 33.9-, 2.2-, and 5.2-fold higher in RPL, 66.3-, 6.7-, and 2.8-fold higher in RPL-PCOS, and 27.3-, 1.9-, and 3.9-fold higher in RPL-ovarian PCO women than those in controls.
CONCLUSION: Our results showed the significance of MTHFR A1298C and PAI-1 4G/5G mutations in Iranian women suffering from RPL with and without PCOS.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22882325     DOI: 10.1111/aji.12002

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  11 in total

Review 1.  MTHFR 1298A>C Substitution is a Strong Candidate for Analysis in Recurrent Pregnancy Loss: Evidence from 14,289 Subjects.

Authors:  Poonam Mehta; Rahul Vishvkarma; Kiran Singh; Singh Rajender
Journal:  Reprod Sci       Date:  2021-03-19       Impact factor: 3.060

2.  Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.

Authors:  Xuejiao Li; Yukun Liu; Rui Zhang; Jianping Tan; Libin Chen; Yinglin Liu
Journal:  Med Sci Monit       Date:  2015-04-11

3.  Is MTHFR 677 C>T Polymorphism Clinically Important in Polycystic Ovarian Syndrome (PCOS)? A Case-Control Study, Meta-Analysis and Trial Sequential Analysis.

Authors:  S Justin Carlus; Saumya Sarkar; Sandeep Kumar Bansal; Vertika Singh; Kiran Singh; Rajesh Kumar Jha; Nirmala Sadasivam; Sri Revathy Sadasivam; P S Gireesha; Kumarasamy Thangaraj; Singh Rajender
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

4.  Association between Thrombophilic Genes Polymorphisms and Recurrent Pregnancy Loss Susceptibility in the Iranian Population: a Systematic Review and Meta-Analysis

Authors:  Mahdieh Kamali; Sedigheh Hantoushzadeh; Sedigheh Borna; Hossein Neamatzadeh; Mahta Mazaheri; Mahmood Noori-Shadkam; Fatemeh Haghighi
Journal:  Iran Biomed J       Date:  2017-07-23

5.  Polymorphisms in the Estrogen Receptor Beta Gene and the Risk of Unexplained Recurrent Spontaneous Abortion.

Authors:  Marzieh Mahdavipour; Saeed Zarei; Ramina Fatemi; Haleh Edalatkhah; Hamed Heidari-Vala; Mahmood Jeddi-Tehrani; Farah Idali
Journal:  Avicenna J Med Biotechnol       Date:  2017 Jul-Sep

6.  Prevalence of Methylenetetrahydrofolate Reductase C677T Polymorphism in women with Polycystic Ovary Syndrome in southeast of Iran.

Authors:  A Naghavi; H Mozdarani; M Garshasbi; M Yaghmaei
Journal:  J Med Life       Date:  2015

Review 7.  Potential genetic polymorphisms predicting polycystic ovary syndrome.

Authors:  Yao Chen; Shu-Ying Fang
Journal:  Endocr Connect       Date:  2018-04-05       Impact factor: 3.335

8.  Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies.

Authors:  Lihong Wang; Wenting Xu; Caihong Wang; Mengyu Tang; Yujia Zhou
Journal:  Oncotarget       Date:  2017-06-14

9.  Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.

Authors:  Ying Xiong; Ce Bian; Xiaojuan Lin; Xiaoli Wang; Kehui Xu; Xia Zhao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

10.  Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms in Male Partners of Recurrent Miscarriage Couples.

Authors:  Somayeh-Sadat Tara; Fatemeh Ghaemimanesh; Saeed Zarei; Fakhreddin Reihani-Sabet; Zhamak Pahlevanzadeh; Mohammad Hosein Modarresi; Mahmood Jeddi-Tehrani
Journal:  J Reprod Infertil       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.